Drugging the p53 pathway: understanding the route to clinical efficacy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drugging the p53 pathway: understanding the route to clinical efficacy
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 13, Issue 3, Pages 217-236
Publisher
Springer Nature
Online
2014-02-28
DOI
10.1038/nrd4236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclotherapy: opening a therapeutic window in cancer treatment
- (2015) Ingeborg M.M. van Leeuwen Oncotarget
- Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
- (2014) Ramiro París et al. CELL CYCLE
- In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition
- (2014) Siau Jia Wei et al. PLoS One
- Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach
- (2013) Mariana Leão et al. BIOCHEMICAL PHARMACOLOGY
- Affinity-based screening of MDM2/MDMX–p53 interaction inhibitors by chemical array: Identification of novel peptidic inhibitors
- (2013) Taro Noguchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Prognostic impact and targeting of CRM1 in acute myeloid leukemia
- (2013) K. Kojima et al. BLOOD
- Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
- (2013) Min Lu et al. CANCER CELL
- MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
- (2013) C. Tovar et al. CANCER RESEARCH
- Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4
- (2013) M. Gutekunst et al. CANCER RESEARCH
- Non-Cell-Autonomous Tumor Suppression by p53
- (2013) Amaia Lujambio et al. CELL
- On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: A Brownian dynamics study
- (2013) Karim ElSawy et al. CELL CYCLE
- Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest
- (2013) Changyou Li et al. CELL CYCLE
- A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis
- (2013) M Kracikova et al. CELL DEATH AND DIFFERENTIATION
- Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors
- (2013) Felix Gonzalez-Lopez de Turiso et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, in Vitro, and in Cell Studies of a New Series of [Indoline-3,2′-thiazolidine]-Based p53 Modulators
- (2013) Alessia Bertamino et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
- (2013) Qingjie Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
- (2013) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide
- (2013) Yanbin Ji et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Small molecule induced reactivation of mutant p53 in cancer cells
- (2013) Xiangrui Liu et al. NUCLEIC ACIDS RESEARCH
- Inhibition of Nutlin-Resistant HDM2 Mutants by Stapled Peptides
- (2013) Siau Jia Wei et al. PLoS One
- Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET
- (2013) R. Shalom-Feuerstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- APR-246/PRIMA-1MET rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations
- (2013) J. Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy
- (2013) K. Shchors et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a second Nutlin-3 responsive interaction site in the N-terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometry
- (2013) Lenka Hernychova et al. PROTEOMICS
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development
- (2013) Binh Vu et al. ACS Medicinal Chemistry Letters
- Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
- (2013) Christopher D. Wassman et al. Nature Communications
- p53 DNA Binding Cooperativity Is Essential for Apoptosis and Tumor Suppression In Vivo
- (2013) Oleg Timofeev et al. Cell Reports
- p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
- (2013) Liz J. Valente et al. Cell Reports
- Stabilizing the Pro-Apoptotic BimBH3 Helix (BimSAHB) Does Not Necessarily Enhance Affinity or Biological Activity
- (2012) Toru Okamoto et al. ACS Chemical Biology
- Stapled Peptides with Improved Potency and Specificity That Activate p53
- (2012) Christopher J. Brown et al. ACS Chemical Biology
- Structural insights into the dual-targeting mechanism of Nutlin-3
- (2012) Jae-Sun Shin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia
- (2012) M. S. Davids et al. BLOOD
- Correlation ofTP53andMDM2genotypes with response to therapy in sarcoma
- (2012) Hege O. Ohnstad et al. CANCER
- Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib
- (2012) Ling Li et al. CANCER CELL
- ATM Phosphorylation of Mdm2 Ser394 Regulates the Amplitude and Duration of the DNA Damage Response in Mice
- (2012) Hugh S. Gannon et al. CANCER CELL
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924
- (2012) J. L. Blank et al. CANCER RESEARCH
- Small molecules that bind the Mdm2 RING stabilize and activate p53
- (2012) P. Roxburgh et al. CARCINOGENESIS
- Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
- (2012) Tongyuan Li et al. CELL
- Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML
- (2012) Thanh-Trang Vo et al. CELL
- An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells
- (2012) Ingeborg M.M. van Leeuwen et al. CELL CYCLE
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX
- (2012) Ryan E Henry et al. EMBO JOURNAL
- Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
- (2012) Alexander H Stegh EXPERT OPINION ON THERAPEUTIC TARGETS
- Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
- (2012) S. P. Glaser et al. GENES & DEVELOPMENT
- The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status
- (2012) G. Zauli et al. HAEMATOLOGICA
- Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy
- (2012) Refik Kayali et al. HUMAN MOLECULAR GENETICS
- Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance inTP53wild-type ovarian cancer cells
- (2012) Roser Mir et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction
- (2012) Yosup Rew et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Expeditious Synthesis of the MDM2–p53 Inhibitor AM-8553
- (2012) Brian S. Lucas et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Ordering of the N-Terminus of Human MDM2 by Small Molecule Inhibitors
- (2012) Klaus Michelsen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53
- (2012) Rainer Wilcken et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated by Point Mutations of p53, but Can Be Overcome with the p53 Targeting Agent RITA
- (2012) R. J. Jones et al. MOLECULAR CANCER THERAPEUTICS
- Association of themiR-146aC>G,miR-149T>C,miR-196a2T>C, andmiR-499A>G polymorphisms with gastric cancer risk and survival in the korean population
- (2012) Dae Ho Ahn et al. MOLECULAR CARCINOGENESIS
- ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53
- (2012) Kelly D Sullivan et al. Nature Chemical Biology
- MDM4 is a key therapeutic target in cutaneous melanoma
- (2012) Agnieszka Gembarska et al. NATURE MEDICINE
- Siladenoserinols A–L: New Sulfonated Serinol Derivatives from a Tunicate as Inhibitors of p53–Hdm2 Interaction
- (2012) Yuichi Nakamura et al. ORGANIC LETTERS
- Improved eIF4E Binding Peptides by Phage Display Guided Design: Plasticity of Interacting Surfaces Yield Collective Effects
- (2012) Weizhuang Zhou et al. PLoS One
- A Spiroligomer α-Helix Mimic That Binds HDM2, Penetrates Human Cells and Stabilizes HDM2 in Cell Culture
- (2012) Zachary Z. Brown et al. PLoS One
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
- (2012) B. Graves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
- (2012) R W Rooswinkel et al. Cell Death & Disease
- Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation
- (2011) Teng Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
- (2011) Jane M Valentine et al. BMC CANCER
- Translational approaches targeting the p53 pathway for anti-cancer therapy
- (2011) Frank Essmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression
- (2011) Colleen A. Brady et al. CELL
- BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death
- (2011) Mark Wade et al. CELL CYCLE
- NPMc+ AML cell line shows differential protein expression and lower sensitivity to DNA-damaging and p53-inducing anticancer compounds
- (2011) Qiao Jing Lew et al. CELL CYCLE
- Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs
- (2011) Rosa Puca et al. CELL CYCLE
- Mechanism-specific signatures for small-molecule p53 activators
- (2011) Ingeborg M.M. van Leeuwen et al. CELL CYCLE
- Understanding Small-Molecule Binding to MDM2: Insights into Structural Effects of Isoindolinone Inhibitors from NMR Spectroscopy
- (2011) Christiane Riedinger et al. Chemical Biology & Drug Design
- iASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe
- (2011) L. Jiang et al. CLINICAL CANCER RESEARCH
- PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
- (2011) R. Zandi et al. CLINICAL CANCER RESEARCH
- Validation of MdmX as a therapeutic target for reactivating p53 in tumors
- (2011) D. Garcia et al. GENES & DEVELOPMENT
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein−Protein Interaction: Structure−Activity Studies Leading to Improved Potency
- (2011) Ian R. Hardcastle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Two Reactive Cysteine Residues in the Tumor Suppressor Protein p53 Using Top-Down FTICR Mass Spectrometry
- (2011) Jenna Scotcher et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex
- (2011) M Konopleva et al. LEUKEMIA
- Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia
- (2011) E McCormack et al. LEUKEMIA
- MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
- (2011) Christian Tovar et al. Molecular Cancer
- Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells
- (2011) Marc J. Rigatti et al. MOLECULAR CARCINOGENESIS
- Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
- (2011) M H Aziz et al. ONCOGENE
- p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
- (2011) Matthias Gutekunst et al. PLoS One
- C-Terminal Substitution of MDM2 Interacting Peptides Modulates Binding Affinity by Distinctive Mechanisms
- (2011) Christopher J. Brown et al. PLoS One
- Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages
- (2011) D. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
- (2011) M Michaelis et al. Cell Death & Disease
- Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
- (2010) Isabelle Sermet-Gaudelus et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Robust Generation of Lead Compounds for Protein-Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists
- (2010) Anna Czarna et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim
- (2010) L. Happo et al. BLOOD
- Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
- (2010) D. Yecies et al. BLOOD
- Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia
- (2010) J. Long et al. BLOOD
- Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma
- (2010) Manujendra N. Saha et al. CANCER BIOLOGY & THERAPY
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
- (2010) Federico Bernal et al. CANCER CELL
- Blockade of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase and Murine Double Minute Synergistically Induces Apoptosis in Acute Myeloid Leukemia via BH3-Only Proteins Puma and Bim
- (2010) W. Zhang et al. CANCER RESEARCH
- Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy
- (2010) Meng Ling Choong et al. CELL CYCLE
- Life or death
- (2010) Katharina Schlereth et al. CELL CYCLE
- Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
- (2010) C F Cheok et al. CELL DEATH AND DIFFERENTIATION
- Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant
- (2010) Nicolas Basse et al. CHEMISTRY & BIOLOGY
- Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway
- (2010) G. Zauli et al. CLINICAL CANCER RESEARCH
- Regulation of the p53 pathway by ubiquitin and related proteins
- (2010) Andreas Hock et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Identification and Characterization of the First Small Molecule Inhibitor of MDMX
- (2010) Damon Reed et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic Mutational Analysis of Peptide Inhibition of the p53–MDM2/MDMX Interactions
- (2010) Chong Li et al. JOURNAL OF MOLECULAR BIOLOGY
- The missing Zinc: p53 misfolding and cancer
- (2010) Stewart N. Loh Metallomics
- Targeted Quantitation of Site-Specific Cysteine Oxidation in Endogenous Proteins Using a Differential Alkylation and Multiple Reaction Monitoring Mass Spectrometry Approach
- (2010) Jason M. Held et al. MOLECULAR & CELLULAR PROTEOMICS
- 1,25-Dihydroxyvitamin D3 Enhances the Apoptotic Activity of MDM2 Antagonist Nutlin-3a in Acute Myeloid Leukemia Cells Expressing Wild-type p53
- (2010) T. Thompson et al. MOLECULAR CANCER THERAPEUTICS
- DNA Binding Cooperativity of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
- (2010) Katharina Schlereth et al. MOLECULAR CELL
- Translating p53 into the clinic
- (2010) Chit Fang Cheok et al. Nature Reviews Clinical Oncology
- Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides
- (2010) Célia Floquet et al. NUCLEIC ACIDS RESEARCH
- MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy
- (2010) A S Azmi et al. ONCOGENE
- PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73
- (2010) N Rökaeus et al. ONCOGENE
- Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells
- (2010) R Puca et al. ONCOGENE
- D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms
- (2010) M. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
- (2010) D. S. Auld et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding
- (2010) Joel L. Kaar et al. PROTEIN SCIENCE
- DNA damage response to the Mdm2 inhibitor Nutlin-3
- (2009) Rajeev Verma et al. BIOCHEMICAL PHARMACOLOGY
- Pharmaceuticals Targeting Nonsense Mutations in Genetic Diseases
- (2009) Steven M. Rowe et al. BIODRUGS
- Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML
- (2009) B. Z. Carter et al. BLOOD
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
- (2009) M. Michaelis et al. CANCER RESEARCH
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- MDM2 Antagonist Nutlin-3 Displays Antiproliferative and Proapoptotic Activity in Mantle Cell Lymphoma
- (2009) Y. Tabe et al. CLINICAL CANCER RESEARCH
- Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX
- (2009) Jason Phan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and Optimization of Chromenotriazolopyrimidines as Potent Inhibitors of the Mouse Double Minute 2−Tumor Protein 53 Protein−Protein Interaction
- (2009) John G. Allen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adaptive Evolution of p53 Thermodynamic Stability
- (2009) Kian Hoe Khoo et al. JOURNAL OF MOLECULAR BIOLOGY
- Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
- (2009) Tom Van Maerken et al. JNCI-Journal of the National Cancer Institute
- Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?
- (2009) Mark Wade et al. MOLECULAR CANCER RESEARCH
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53
- (2009) S. Sur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression
- (2009) D. S. Auld et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
- (2009) M. Pazgier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Biology of the Tumor Suppressor p53
- (2008) Andreas C. Joerger et al. Annual Review of Biochemistry
- Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia
- (2008) K. Kojima et al. BLOOD
- Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator
- (2008) Sonia Lain et al. CANCER CELL
- In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute
- (2008) E M Michalak et al. CELL DEATH AND DIFFERENTIATION
- Multiple Peptide Conformations Give Rise to Similar Binding Affinities: Molecular Simulations of p53-MDM2
- (2008) Shubhra Ghosh Dastidar et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
- (2008) Eitan Kerem et al. LANCET
- Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
- (2008) J. Kitagaki et al. MOLECULAR CANCER THERAPEUTICS
- Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53
- (2008) S. Supiot et al. MOLECULAR CANCER THERAPEUTICS
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA
- (2008) Dmitry B. Veprintsev et al. NUCLEIC ACIDS RESEARCH
- Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
- (2008) S. Shangary et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
- (2008) F. M. Boeckler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Introducing sense into nonsense in treatments of human genetic diseases
- (2008) Liat Linde et al. TRENDS IN GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search